From cancer immunotherapy to diabetes and weight loss breakthroughs, 2025’s top-selling drugs highlight how pharmaceutical ...

As drug development increasingly targets multiple indications, pharma companies must make strategic branding ...

Pfizer has terminated a Phase II study of its CD47 immune checkpoint inhibitor, maplirpacept, due to low recruitment. In an ...

It boasts more than 80 programs in phase 2 or phase 3 studies. Even with a 25% success rate for these, that should translate ...

On 16 March 2024, New Delhi Police arrested Neeraj Chauhan and others for selling fake anti-cancer drugs to patients at a ...

The achievement of that goal in India, which ranks third in obesity numbers after the US and China, will shatter the record ...

CHICAGO — In this video, Megan Kruse, MD, breast medical oncologist at Cleveland Clinic, discusses primary results from ASCENT-04 evaluating sacituzumab govitecan plus pembrolizumab in ...

VIENNA - CEL-SCI Corporation (NYSE American: CVM), a small-cap biotech company with a market capitalization of approximately $12 million, on Wednesday welcomed the FDA’s approval of Merck’s Keytruda ...

VIENNA - CEL-SCI Corporation (NYSE American: CVM), a small-cap biotech company with a market capitalization of approximately $12 million, on Wednesday welcomed the FDA’s approval of Merck’s Keytruda ...

SAN ANTONIO — Finding out you have a deadly disease is never a pleasant experience, But if you have a good support system and the right information about your illness, the direction you go could ...

Kraft Heinz has announced it will stop launching any new U.S. food products containing FD&C (Food, Drug & Cosmetic) artificial colors and plans to remove the dyes from its existing lineup before ...